Trademark: 90593460
Word
STELLAR TRIALBRIDGE
Status
Registered
Status Code
700
Status Date
Tuesday, June 13, 2023
Serial Number
90593460
Registration Number
7081324
Registration Date
Tuesday, June 13, 2023
Mark Type
3000
Filing Date
Monday, March 22, 2021
Published for Opposition
Tuesday, April 19, 2022

Trademark Owner History
STELLAR IDEA LABS, INC. - Original Registrant
greatEvents, LLC - Original Applicant

Classifications
42 Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, clinical trial design and protocol development, clinical trial planning and management, clinical trial user and learning management, clinical trial operational reporting and analytics, clinical trial randomization and trial supply management, clinical trial monitoring and events capture and clinical data capture, management and reporting; Application service provider (ASP) featuring software using artificial intelligence for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of pharmaceuticals and medical devices, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Platform as a service (PAAS) featuring computer software platforms for use in managing data and information in the field of medical clinical trials and research, for use in clinical trial monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and research, and for use in clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Scientific research and development; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals
The mark consists of the wording "Stellar TrialBridge" in stylized font with a horizontal line between the words, and a stylized laboratory flask featuring two double helix designs and seven shaded hexagons shapes, two of which are connected.

Trademark Events
Jun 13, 2023
Notice Of Registration Confirmation Emailed
Jun 13, 2023
Registered-Principal Register
May 12, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
May 11, 2023
Allowed Principal Register - Sou Accepted
May 10, 2023
Teas/Email Correspondence Entered
May 9, 2023
Correspondence Received In Law Office
May 9, 2023
Teas Response To Office Action Received
Feb 10, 2023
Notification Of Non-Final Action E-Mailed
Feb 10, 2023
Non-Final Action E-Mailed
Feb 10, 2023
Su - Non-Final Action - Written
Jan 18, 2023
Statement Of Use Processing Complete
Dec 14, 2022
Use Amendment Filed
Jan 18, 2023
Case Assigned To Intent To Use Paralegal
Dec 14, 2022
Teas Statement Of Use Received
Jun 14, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 17, 2022
Approved For Pub - Principal Register
Mar 15, 2022
Teas/Email Correspondence Entered
Mar 15, 2022
Correspondence Received In Law Office
Mar 15, 2022
Teas Response To Office Action Received
Nov 15, 2021
Notification Of Non-Final Action E-Mailed
Nov 15, 2021
Non-Final Action E-Mailed
Nov 15, 2021
Non-Final Action Written
Sep 10, 2021
Assigned To Examiner
Jun 25, 2021
Notice Of Design Search Code E-Mailed
Jun 24, 2021
New Application Office Supplied Data Entered
Apr 7, 2021
Automatic Update Of Assignment Of Ownership
Mar 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24